BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Michonneau D, Latis E, Curis E, Dubouchet L, Ramamoorthy S, Ingram B, de Latour RP, Robin M, de Fontbrune FS, Chevret S, Rogge L, Socié G. Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites. Nat Commun 2019;10:5695. [PMID: 31836702 DOI: 10.1038/s41467-019-13498-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Lin D, Hu B, Li P, Zhao Y, Xu Y, Wu D. Roles of the intestinal microbiota and microbial metabolites in acute GVHD. Exp Hematol Oncol 2021;10:49. [PMID: 34706782 DOI: 10.1186/s40164-021-00240-3] [Reference Citation Analysis]
2 Hayase E, Jenq RR. Too much TMAO and GVHD. Blood 2020;136:383-5. [PMID: 32702126 DOI: 10.1182/blood.2020006104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fujiwara H. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation. Front Immunol 2021;12:703298. [PMID: 34512627 DOI: 10.3389/fimmu.2021.703298] [Reference Citation Analysis]
4 Nguyen CL, Docampo MD, van den Brink MR, Markey KA. The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms. Curr Opin Genet Dev 2021;66:25-35. [PMID: 33388483 DOI: 10.1016/j.gde.2020.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hou Y, He D, Ye L, Wang G, Zheng Q, Hao H. An improved detection and identification strategy for untargeted metabolomics based on UPLC-MS. J Pharm Biomed Anal 2020;191:113531. [PMID: 32889345 DOI: 10.1016/j.jpba.2020.113531] [Reference Citation Analysis]
6 Kalani Roy M, La Carpia F, Cendali F, Fernando S, Moriconi C, Wojczyk BS, Wang L, Nemkov T, Hod EA, D'Alessandro A. Irradiation Causes Alterations of Polyamine, Purine, and Sulfur Metabolism in Red Blood Cells and Multiple Organs. J Proteome Res 2022. [PMID: 35043621 DOI: 10.1021/acs.jproteome.1c00912] [Reference Citation Analysis]
7 Masetti R, Zama D, Leardini D, Muratore E, Turroni S, Brigidi P, Pession A. Microbiome-Derived Metabolites in Allogeneic Hematopoietic Stem Cell Transplantation. Int J Mol Sci 2021;22:1197. [PMID: 33530464 DOI: 10.3390/ijms22031197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wieder C, Frainay C, Poupin N, Rodríguez-Mier P, Vinson F, Cooke J, Lai RP, Bundy JG, Jourdan F, Ebbels T. Pathway analysis in metabolomics: Recommendations for the use of over-representation analysis. PLoS Comput Biol 2021;17:e1009105. [PMID: 34492007 DOI: 10.1371/journal.pcbi.1009105] [Reference Citation Analysis]
9 Rangel-huerta OD, de la Torre-aguilar MJ, Mesa MD, Flores-rojas K, Pérez-navero JL, Baena-gómez MA, Gil A, Gil-campos M. The Metabolic Impact of Two Different Parenteral Nutrition Lipid Emulsions in Children after Hematopoietic Stem Cell Transplantation: A Lipidomics Investigation. IJMS 2022;23:3667. [DOI: 10.3390/ijms23073667] [Reference Citation Analysis]
10 Markey KA. The Post-HCT Intestinal Microbiome: Who are the Key Disruptors and How Long does the Damage Last? Transplant Cell Ther 2022;28:121-2. [PMID: 35279229 DOI: 10.1016/j.jtct.2022.02.005] [Reference Citation Analysis]
11 Zhang J, Du Y, Zhang Y, Xu Y, Fan Y, Li Y. 1H-NMR Based Metabolomics Technology Identifies Potential Serum Biomarkers of Colorectal Cancer Lung Metastasis in a Mouse Model. CMAR 2022;Volume 14:1457-69. [DOI: 10.2147/cmar.s348981] [Reference Citation Analysis]
12 Kaźmierczak-Siedlecka K, Skonieczna-Żydecka K, Biliński J, Roviello G, Iannone LF, Atzeni A, Sobocki BK, Połom K. Gut Microbiome Modulation and Faecal Microbiota Transplantation Following Allogenic Hematopoietic Stem Cell Transplantation. Cancers (Basel) 2021;13:4665. [PMID: 34572894 DOI: 10.3390/cancers13184665] [Reference Citation Analysis]
13 Latis E, Michonneau D, Leloup C, Varet H, Peffault de Latour R, Bianchi E, Socié G, Rogge L; CRYOSTEM Consortium. Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD. Blood Adv 2020;4:3927-42. [PMID: 32818226 DOI: 10.1182/bloodadvances.2019001032] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
14 Yu J, Sun H, Cao W, Han L, Song Y, Wan D, Jiang Z. Applications of gut microbiota in patients with hematopoietic stem-cell transplantation. Exp Hematol Oncol 2020;9:35. [PMID: 33292670 DOI: 10.1186/s40164-020-00194-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Vandenhove B, Canti L, Schoemans H, Beguin Y, Baron F, Graux C, Kerre T, Servais S. How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation. Front Immunol 2020;11:583564. [PMID: 33193397 DOI: 10.3389/fimmu.2020.583564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Nong F, Luo S, Liang Y, Zhao Z, Xing S, Wen B, Zhou L. Evaluation of the effect of Dahuang-Mudan decoction on TNBS-induced colitis using UPLC-QTOF/MS-based metabolomic analysis. Biomed Chromatogr 2021;35:e5003. [PMID: 33063880 DOI: 10.1002/bmc.5003] [Reference Citation Analysis]
17 Haring E, Uhl FM, Andrieux G, Proietti M, Bulashevska A, Sauer B, Braun LM, de Vega Gomez E, Esser PR, Martin SF, Pfeifer D, Follo M, Schmitt-Graeff A, Buescher J, Duyster J, Grimbacher B, Boerries M, Pearce EL, Zeiser R, Apostolova P. Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect. Haematologica 2021;106:2131-46. [PMID: 32675222 DOI: 10.3324/haematol.2019.242990] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
18 Rafei H, Jenq RR. Microbiome-intestine cross talk during acute graft-versus-host disease. Blood 2020;136:401-9. [PMID: 32526029 DOI: 10.1182/blood.2019000950] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
19 Qayed M, Michonneau D, Socié G, Waller EK. Indole derivatives, microbiome and graft versus host disease. Curr Opin Immunol 2021;70:40-7. [PMID: 33647539 DOI: 10.1016/j.coi.2021.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Newell LF, Holtan SG. Acute GVHD: think before you treat. Hematology Am Soc Hematol Educ Program 2021;2021:642-7. [PMID: 34889409 DOI: 10.1182/hematology.2021000300] [Reference Citation Analysis]
21 Messikommer A, Seipel K, Byrne S, Valk PJM, Pabst T, Luedtke NW. RNA Targeting in Acute Myeloid Leukemia. ACS Pharmacol Transl Sci 2020;3:1225-32. [PMID: 33344899 DOI: 10.1021/acsptsci.0c00120] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Chae S, Kim DJ, Cho JY. Complex influences of gut microbiome metabolism on various drug responses. Transl Clin Pharmacol 2020;28:7-16. [PMID: 32274377 DOI: 10.12793/tcp.2020.28.e3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
23 Andrlová H, van den Brink MRM, Markey KA. An Unconventional View of T Cell Reconstitution After Allogeneic Hematopoietic Cell Transplantation. Front Oncol 2020;10:608923. [PMID: 33680931 DOI: 10.3389/fonc.2020.608923] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Le Bastard Q, Chevallier P, Montassier E. Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft vs host disease. World J Gastroenterol 2021; 27(45): 7792-7800 [PMID: 34963742 DOI: 10.3748/wjg.v27.i45.7792] [Reference Citation Analysis]
25 Chen S, Zeiser R. Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol 2020;11:1854. [PMID: 33013836 DOI: 10.3389/fimmu.2020.01854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Yalcin SS, Aksu T, Kuskonmaz B, Ozbek NY, Pérez-Brocal V, Celik M, Uckan Cetinkaya D, Moya A, Dinleyici EC. Intestinal mycobiota composition and changes in children with thalassemia who underwent allogeneic hematopoietic stem cell transplantation. Pediatr Blood Cancer 2021;:e29411. [PMID: 34699120 DOI: 10.1002/pbc.29411] [Reference Citation Analysis]
27 Dubouchet L, Todorov H, Seurinck R, Vallet N, Van Gassen S, Corneau A, Blanc C, Zouali H, Boland A, Deleuze JF, Ingram B, de Latour RP, Saeys Y, Socié G, Michonneau D. Operational tolerance after hematopoietic stem cell transplantation is characterized by distinct transcriptional, phenotypic, and metabolic signatures. Sci Transl Med 2022;14:eabg3083. [PMID: 35196024 DOI: 10.1126/scitranslmed.abg3083] [Reference Citation Analysis]
28 Socié G, Kean LS, Zeiser R, Blazar BR. Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host disease. J Clin Invest 2021;131:149296. [PMID: 34101618 DOI: 10.1172/JCI149296] [Reference Citation Analysis]
29 Zheng L, Wen XL, Duan SL. Role of metabolites derived from gut microbiota in inflammatory bowel disease. World J Clin Cases 2022; 10(9): 2658-2675 [DOI: 10.12998/wjcc.v10.i9.2658] [Reference Citation Analysis]
30 Kumari R, Palaniyandi S, Hildebrandt GC. Metabolic Reprogramming-A New Era How to Prevent and Treat Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Has Begun. Front Pharmacol 2020;11:588449. [PMID: 33343357 DOI: 10.3389/fphar.2020.588449] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Van Lier YF, Van den Brink MRM, Hazenberg MD, Markey KA. The post-hematopoietic cell transplantation microbiome: relationships with transplant outcome and potential therapeutic targets. Haematologica 2021;106:2042-53. [PMID: 33882637 DOI: 10.3324/haematol.2020.270835] [Reference Citation Analysis]
32 Kouidhi S, Souai N, Zidi O, Mosbah A, Lakhal A, Ben Othmane T, Belloumi D, Ben Ayed F, Asimakis E, Stathopoulou P, Cherif A, Tsiamis G. High Throughput Analysis Reveals Changes in Gut Microbiota and Specific Fecal Metabolomic Signature in Hematopoietic Stem Cell Transplant Patients. Microorganisms 2021;9:1845. [PMID: 34576740 DOI: 10.3390/microorganisms9091845] [Reference Citation Analysis]
33 Payen M, Nicolis I, Robin M, Michonneau D, Delannoye J, Mayeur C, Kapel N, Berçot B, Butel MJ, Le Goff J, Socié G, Rousseau C. Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity. Blood Adv 2020;4:1824-32. [PMID: 32353108 DOI: 10.1182/bloodadvances.2020001531] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
34 Mohamed FA, Thangavelu G, Rhee SY, Sage PT, O'Connor RS, Rathmell JC, Blazar BR. Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease. Front Immunol 2021;12:757836. [PMID: 34712243 DOI: 10.3389/fimmu.2021.757836] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Song Q, Nasri U, Zeng D. Steroid-Refractory Gut Graft-Versus-Host Disease: What We Have Learned From Basic Immunology and Experimental Mouse Model. Front Immunol 2022;13:844271. [DOI: 10.3389/fimmu.2022.844271] [Reference Citation Analysis]
36 Di Ciaula A, Stella A, Bonfrate L, Wang DQH, Portincasa P. Gut Microbiota between Environment and Genetic Background in Familial Mediterranean Fever (FMF). Genes (Basel) 2020;11:E1041. [PMID: 32899315 DOI: 10.3390/genes11091041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
37 Hong T, Wang R, Wang X, Yang S, Wang W, Gao Q, Zhang X. Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance. Front Immunol 2021;12:644982. [PMID: 33815399 DOI: 10.3389/fimmu.2021.644982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Zhen J, Ren Y, Zhang H, Yuan X, Wang L, Shen H, Liu P, Chen Y. Effect of Different Dietary Regimes on the Gut Microbiota and Fecal Metabolites of Père David’s Deer. Animals 2022;12:584. [DOI: 10.3390/ani12050584] [Reference Citation Analysis]
39 Pirozzolo I, Li Z, Sepulveda M, Alegre ML. Influence of the microbiome on solid organ transplant survival. J Heart Lung Transplant 2021;40:745-53. [PMID: 34030971 DOI: 10.1016/j.healun.2021.04.004] [Reference Citation Analysis]
40 Li Y, Toothaker JM, Ben-Simon S, Ozeri L, Schweitzer R, McCourt BT, McCourt CC, Werner L, Snapper SB, Shouval DS, Khatib S, Koren O, Agnihorti S, Tseng G, Konnikova L. In utero human intestine harbors unique metabolome, including bacterial metabolites. JCI Insight 2020;5:138751. [PMID: 33001863 DOI: 10.1172/jci.insight.138751] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
41 Giaccone L, Faraci DG, Butera S, Lia G, Di Vito C, Gabrielli G, Cerrano M, Mariotti J, Dellacasa C, Felicetti F, Brignardello E, Mavilio D, Bruno B. Biomarkers for acute and chronic graft versus host disease: state of the art. Expert Rev Hematol 2021;14:79-96. [PMID: 33297779 DOI: 10.1080/17474086.2021.1860001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Barupal DK, Mahajan P, Fakouri-Baygi S, Wright RO, Arora M, Teitelbaum SL. CCDB: A database for exploring inter-chemical correlations in metabolomics and exposomics datasets. Environ Int 2022;164:107240. [PMID: 35461097 DOI: 10.1016/j.envint.2022.107240] [Reference Citation Analysis]
43 Lindner S, Peled JU. Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation. Curr Opin Hematol 2020;27:360-7. [PMID: 33003084 DOI: 10.1097/MOH.0000000000000616] [Reference Citation Analysis]
44 Zheng L, Wen X, Duan S. Role of metabolites derived from gut microbiota in inflammatory bowel disease. WJCC 2022;10:2660-77. [DOI: 10.12998/wjcc.v10.i9.2660] [Reference Citation Analysis]
45 Wojciech L, Tan KSW, Gascoigne NRJ. Taming the Sentinels: Microbiome-Derived Metabolites and Polarization of T Cells. Int J Mol Sci 2020;21:E7740. [PMID: 33086747 DOI: 10.3390/ijms21207740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Braverman EL, Waltz G, Byersdorfer CA. Immunometabolism in haematopoietic stem cell transplantation and adoptive cellular therapies. Curr Opin Hematol 2020;27:353-9. [PMID: 33003083 DOI: 10.1097/MOH.0000000000000615] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Chang CC, Hayase E, Jenq RR. The role of microbiota in allogeneic hematopoietic stem cell transplantation. Expert Opin Biol Ther 2021;21:1121-31. [PMID: 33412949 DOI: 10.1080/14712598.2021.1872541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Tanaka JS, Young RR, Heston SM, Jenkins K, Spees LP, Sung AD, Corbet K, Thompson JC, Bohannon L, Martin PL, Stokhuyzen A, Vinesett R, Ward DV, Bhattarai SK, Bucci V, Arshad M, Seed PC, Kelly MS. Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2020;26:2053-60. [PMID: 32682948 DOI: 10.1016/j.bbmt.2020.07.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]